Lots of cell lines (CHO cells, hybridoma, HEK293, yeast, insect cell, plant cells, prokaryotic, ...) are available on the market to produce recombinant proteins and monoclonal antibodies (mAbs), viral vectors, small molecules, ... Those cells meet the biomanufacturing needs of industrials for Biotech Pharma and IVD sectors.
When evaluating a particular expression systems, several factors need to be taken into account. First, they need to be easily genetically modified in order to ensure high productivity capacity and high sucess rate during stable transfection step. Then, these host cell lines have to confer the proper post translational modifications of folded recombinant proteins. At last, the chosen expression system has to be safe and not susceptible to adventitious agents.
The stability and the productivity of your cell lines is essential to ensure success by developping and manufacturing your proteins at lower cost, quickly and in sufficient quantities.
Improving your cell lines represents many advantages and guarantee you get enough material for your Biotech Pharma or IVD application.
AmplyCell has been improving for ten years its Amply™ Technology, in order to improve your profitability.